Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 13.7.2015 | EN | Official Journal of the European Union | C 228/23 |

---

Action brought on 13 May 2015 — Novartis v OHIM — Meda (Zimara)

(Case T-238/15)

(2015/C 228/28)

Language in which the application was lodged: English

Parties

Applicant: Novartis AG (Basel, Switzerland) (represented by: M. Douglas, lawyer)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM)

Other party to the proceedings before the Board of Appeal: Meda AB (Solna, Sweden)

Details of the proceedings before OHIM

Applicant: Other party to the proceedings before the Board of Appeal

Trade mark at issue: Community word mark ‘Zimara’ — Application for registration No 9 782 764

Procedure before OHIM: Opposition proceedings

Contested decision: Decision of the Fifth Board of Appeal of OHIM of 6 March 2015 in Case R 636/2014-5

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | Annul the contested decision; |

|  |  |
| --- | --- |
| — | Order OHIM to pay the costs. |

Plea in law

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) CTMR. |

---

[Top](#document1)